Webcast: Optimizing LDL-C Management Post-MI: Patient Case & Expert Discussions
Expert faculty developed challenging cases to illustrate practical points in the optimization of LDL-C therapy post-MI, including, but not limited to the points illustrated below. At the end of each case, faculty engage in discussions to offer clinical pearls and expert insights on the cases.
Category
  • CMHC
Format
  • Webinar recorded
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
17th Annual Cardiometabolic Health Congress On-Demand
Hundreds of practitioners gathered in Boston in October 2022 for the annual conference from Cardiometabolic Health Congress (CMHC).
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • 18.50 ABIM MOC and AMA PRA Category 1 Credit™
  • 18.50 ACPE Pharmacy
  • 18.50 AMA PRA Category 1 Credit™
  • 18.50 ANCC
  • 18.50 CDE
  • 18.50 Participation
A Shifting Paradigm: Translating Research into Treatment Approaches for ALS
Many providers lack knowledge regarding amyotrophic lateral sclerosis (ALS) and may be unaware of available information. Arming providers with an expansive understanding is extremely important.
Category
Format
Credits
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
Overwhelmed and Underdiagnosed: Understanding ADHD in Female Patients
Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in females. The presence of comorbid psychiatric disorders, including depression and anxiety, and obsessive compulsive disorder, may mitigate symptoms and delay diagnosis.
Category
Format
Credits
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
Clinical Spotlight: Pediatric Diagnosis & Treatment for Rett Syndrome
Rett Syndrome is one of the most frequent causes of mental disability in females, with an estimated prevalence of 1 in 10,000 under the age of 12.
Category
  • TME
Format
  • Video
  • Webinar recorded
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC
  • 1.25 Participation
A Closer Look: CDKL5 Deficiency Disorder & Rescue Treatment
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a rare developmental epileptic encephalopathy caused by mutations in the CDLK5 gene. The CDKL5 gene provides instructions for making proteins essential for normal brain and neuron development.
Category
Format
  • Book
Credits
  • 0.25 ACCME (All Other)
  • 0.25 ACCME (MD/DO Only)
  • 0.25 ACPE Pharmacy
  • 0.25 ANCC
Primer: Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Currently, the standard of care for patients with alopecia areata (AA) is insufficient, challenging clinicians to find effective treatments in practice.
Category
  • LivDerm
  • TME
Format
  • Webinar recorded
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Virtual Symposium - Assessing the Evolving Role of GLP1-RAs to Reduce Cardiovascular Risk: Emerging Evidence, Evolving Guidance, and Expert Perspectives
GLP-1 RAs have carved an important role in the management of patients with type 2 diabetes (T2D), not only in glycemic control, but also in reducing cardiovascular and renal risk.
Category
  • CMHC
Format
  • Video
Credits
  • 1.00 ABIM MOC and AMA PRA Category 1 Credit™
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation
The Disproportionate Burden of Heart Failure in Women: Advances & Expert Perspectives to Improve Diagnosis & Treatment
The prevalence of heart failure (HF) is greater in women compared to men; however, significant gaps exist in the management of women with this condition.
Category
  • CMHC
Format
  • Self-study / Enduring
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Virtual Symposium - Escaping the Current Gaps in the Understanding and Treatment of CKD Anemia: Making Sense of Emerging Therapies
Anemia is a common comorbidity in patients with chronic kidney disease (CKD), and is associated with significant morbidity and impacts on quality of life.  The complicated pathophysiology of the condition and the disadvantages associated with current treatments are some of the major barriers that
Category
  • CMHC
Format
  • Video
Credits
  • 1.00 ABIM MOC and AMA PRA Category 1 Credit™
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CDE
  • 1.00 Participation

Pages